Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06247215 · ClinicalTrials.gov registry record
Building Resilience for Advance Care Planning (ACP) in Chinese Americans
A clinical trial, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 125
- Enrollment target
NCT06247215: Completed study, sponsored by University of Illinois at Chicago.
NCT06247215 is a clinical trial that has completed, run by University of Illinois at Chicago. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06247215 has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn about how Chinese Americans engage in advance care planning (ACP) discussions with their family caregivers. The main questions it aims to answer are: 1. How do religious leaders discuss advance care planning and death-related topics with Chinese Americans who are diagnosed with cancer or heart disease in Chicago? 2. Are Chinese Americans living in Chicago ready to participate in ACP discussions with their family? 3. What kind of support and resources are required to engage in end-of-life care discussions among Chinese Americans/immigrants living in Chicago? 4. What do Chinese Americans with cancer, high blood pressure, or heart disease and their family members think about an ACP pamphlet made for Chinese Americans? Participants will share their experience either through interviews or a survey.
Primary Outcome
The Advance Care Planning Engagement Survey was used to evaluate the readiness for advance care planning discussions among Chinese Americans living in Chicago.
Interventions
- OTHER Religious leaders
- OTHER Chinese Americans
- OTHER Chinese Americans with end-of-life care discussions
- OTHER Chinese Americans with chronic diseases
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2023-11-08 |
| Est. Completion | 2025-12-18 |
What the finished NCT06247215 record still lists
NCT06247215 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Religious leaders is the first listed.
NCT06247215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06247215 about?
NCT06247215 is a clinical study titled "Building Resilience for Advance Care Planning (ACP) in Chinese Americans". The goal of this observational study is to learn about how Chinese Americans engage in advance care planning (ACP) discussions with their family caregivers. The main questions it aims to answer are: 1. How do religious leaders discuss advance care planning and death-related topics with Chinese Ame...
What is the current status of trial NCT06247215?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2023-11-08. Estimated completion is 2025-12-18.
What interventions are being tested in trial NCT06247215?
The interventions under investigation include: Religious leaders (OTHER), Chinese Americans (OTHER), Chinese Americans with end-of-life care discussions (OTHER), Chinese Americans with chronic diseases (OTHER).
Who is sponsoring clinical trial NCT06247215?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI